[Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].
作者信息
Choay J, Lormeau J C, Petitou M
出版信息
Ann Pharm Fr. 1981 May;39(1):37-44.
PMID:7247232
Abstract
摘要
相似文献
1
[Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].血浆中对Xa因子有活性的低分子量寡糖（作者译）
Ann Pharm Fr. 1981 May;39(1):37-44.
2
3
4
Synthetic irreversible inhibitors of coagulation enzymes.凝血酶的合成不可逆抑制剂。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1982;109(1):33-42.
5
6
Structural studies on a biologically active hexasaccharide obtained from heparin.对从肝素中获得的一种生物活性六糖的结构研究。
Ann N Y Acad Sci. 1981;370:644-9. doi: 10.1111/j.1749-6632.1981.tb29770.x.
7
Immobilization of high-affinity heparin oligosaccharides to radiofrequency plasma-modified polyethylene.将高亲和力肝素寡糖固定于射频等离子体改性的聚乙烯上。
J Biomed Mater Res. 1993 Jun;27(6):811-9. doi: 10.1002/jbm.820270614.
8
Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.遗传性异常抗凝血酶III组分对凝血酶和因子Xa的抑制反应性。
Thromb Haemost. 1980 Oct 31;44(2):92-5.
9
[From heparin to synthetic antithrombotic oligosaccharides].[从肝素到合成抗血栓寡糖]
Bull Acad Natl Med. 2003;187(1):47-56; discussion 56-7.
10
Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.凝血酶原酶复合物的选择性抑制：因子Va改变了因子Xa对一种蜱抗凝肽突变体的大分子识别。
Biochemistry. 1997 Jan 7;36(1):181-91. doi: 10.1021/bi962060g.
引用本文的文献
1
Advances in the preparation and synthesis of heparin and related products.肝素及其相关产品的制备与合成研究进展。
Drug Discov Today. 2020 Dec;25(12):2095-2109. doi: 10.1016/j.drudis.2020.09.011. Epub 2020 Sep 16.
2
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.具有高抗（因子Xa）活性且包含最小抗凝血酶III结合序列的肝素寡糖片段的结构。化学和13C核磁共振研究。
Biochem J. 1981 Sep 1;197(3):599-609. doi: 10.1042/bj1970599.
Zotero 插件